CCS
PGEN icon

Crosspoint Capital Strategies’s Precigen PGEN Stock Holding History

Crosspoint Capital Strategies’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,036
Closed -$112K – 167
2016
Q3 		$112K Hold
4,036
– – 0.15% 28
2016
Q2 		$98K Buy
+4,036
New +$114K 0.1% 40
2016
Q1 		– Sell
-1,621
Closed -$48K – 619
2015
Q4 		$48K Sell
1,621
-715
-31% -$24.1K 0.01% 446
2015
Q3 		$74K Sell
2,336
-146,584
-98% -$7.15M 0.09% 207
2015
Q2 		$7.2M Buy
148,920
+148,780
+106,271% +$6.27M 2.05% 5
2015
Q1 		$6K Buy
+140
New +$5.03K ﹤0.01% 430

Other funds holding PGEN

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Crosspoint Capital Strategies's PGEN Position: Q4 2016 in Review

Crosspoint Capital Strategies sold out of Precigen (PGEN) in Q4 2016, closing a stake of 4,036 shares — an estimated $112K sold.

Crosspoint Capital Strategies first reported a position in PGEN in Q1 2015 and held it in 6 quarters. The position peaked at $7.2M in Q2 2015. 171 funds tracked by Wall St. Rank hold PGEN as of Q4 2016.

  • Crosspoint Capital Strategies reported no remaining Precigen position as of Q4 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 4,036 Precigen shares in Q4 2016, an estimated $112K.
  • Crosspoint Capital Strategies first reported a position in Precigen in Q1 2015 and held it in 6 quarters.
  • Crosspoint Capital Strategies's Precigen position peaked at $7.2M in Q2 2015.
  • 171 funds tracked by Wall St. Rank held Precigen as of Q4 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q4 2016, filed 23 Jan 2017.